Ophthalmic Sutures Market - By Type (Natural, Synthetic), By Material (Nylon, Polyproplene, Silk, PGA), By Coating (Coated, Uncoated), By Material Structure (Monofilament, Multifilament) By Absorption (Absorbable, Non-absorbable), By Application, By End-use & Forecast, 2023-2032
Published on: 2024-08-01 | No of Pages : 240 | Industry : Healthcare
Publisher : MIR | Format : PDF&Excel
Ophthalmic Sutures Market - By Type (Natural, Synthetic), By Material (Nylon, Polyproplene, Silk, PGA), By Coating (Coated, Uncoated), By Material Structure (Monofilament, Multifilament) By Absorption (Absorbable, Non-absorbable), By Application, By End-use & Forecast, 2023-2032
Ophthalmic Sutures Market Size
Ophthalmic Sutures Market size was valued at over USD 791 million in 2022. Driven by the surging incidence of diabetes leading to ophthalmic disorders, the market is slated to register over 6.5% CAGR from 2023 to 2032.
Increasing prevalence of diabetes is further leading to more cases of ophthalmic diseases across the globe. This is further raising the case load of diabetic eye diseases, such as diabetic retinopathy and diabetic macular edema, which causes blindness or poor vision, elevating the demand for ophthalmic sutures.
More than 240 national diabetes associations from over 168 nations have appointed a team of professionals to effectively manage diabetic macular edema cases. Meanwhile, National Center for Biotechnology Information, estimates suggest that over 191 million are expected to suffer from diabetic retinopathy by 2030.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Ophthalmic Sutures Market Size in 2022 | USD 791 million |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 6.5% |
| 2032 Value Projection | USD 1.6 million |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 210 |
| Tables, Charts & Figures | 423 |
| Segments covered | Type, Materials, Coating, Material Structure, Absorption, Application, End-use, and Region. |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
Postoperative complications related to ophthalmic procedures may constrain industry growth
Postoperative complications associated with ophthalmic procedures may negatively impact the ophthalmic sutures market scenario. Risks related to eye-surgeries are greatly elevated due to factors such as lack of essential expertise and proper training for surgeons. The potential complications of eye surgeries include inflammation inside the eye, bleeding, retinal detachment, and infection among others. As per the American Academy of Ophthalmology, immediate eye-surgery-related complications include discomfort and swelling of the eyelid, increased intraocular pressure, and allergic reaction to the antibiotic drop among others.
Ophthalmic Sutures Market Analysis
Based on type, the ophthalmic sutures market size from natural ophthalmic sutures segment is expected to surpass USD 495 million by 2032. Beneficial capabilities of natural ophthalmic sutures, including self-degradation absorption, forming a secure knot, assisting in maintaining adequate strength, non-irritating and carcinogenic characteristics, and the ability to not produce inflammation are augmenting segment progress. Natural ophthalmic sutures also boast of strong pull, good absorption, and the ability to support wound healing. Moreover, they can also be mass-manufactured at low cost and produced easily.
Based on coating, the ophthalmic sutures market from coated sutures segment is likely to grow at over 6% CAGR through 2023 and 2032, driven by the long-lasting properties of coated sutures and their ability to cause minimal tissue reaction. They also reduce friction for ease of tissue movement and offer enhanced suture flexibility. The coating material also allows for the suture to be coated with antibiotics that makes it more infection-resistant. Existing antibiotics used by industry players are depicting sufficient effectiveness against bacterial resistance. Subsequently, coated sutures are being regarded as promising tools to combat surgical site infections.
In terms of end-use, the ophthalmic sutures market is classified into ambulatory surgical centers, hospitals, and others. The ambulatory surgical centers segment valuation is poised to reach nearly USD 425 million by 2032, owing to the rising number of ambulatory surgical centers and surging patient preference for minimally invasive surgical procedures. As per a survey, the rate of surgeries at ASCs is growing consistently in countries such as the U.S., where these facilities are increasingly focusing on improving and speeding up postoperative surgery recovery and offering high-quality, affordable services.
Asia Pacific ophthalmic sutures market is estimated to grow at over 9% CAGR over 2023 and 2032. APAC holds the highest diabetes-related disease burden in the world. The International Diabetes Federation estimates that the total diabetes cases in South-East Asia are likely to reach 113 million by 2030. In China, which is regarded as the nation with the highest number of diabetes cases globally, over 140 million people are suffering from eye diseases. This presents a sizable growth opportunity for industry players that have a presence in the region. U.S. ophthalmic sutures industry is expected to observe a 5.5% CAGR through 2032 owing to growing prevalence of eye diseases in the U.S.
Ophthalmic Sutures Market Share
Some leading ophthalmic sutures market players include
- Geuder AG
- Corza medical
- Unilene
- Asssut Medical
- Mani, Inc.
- Medtronic
- Alcon Inc.
Many of these players are prioritizing partnerships to expand their industry presence. For instance, in November 2022, Corza Medical, a U.S.-based provider of innovative surgical technologies, inked a new partnership with Vortex Surgical, a manufacturer specializing in micro and nano surgical design for retinal surgery, to enter the vitreoretinal surgical field. This will help the company drive technological advancements in the field and enhance its brand visibility with patients.
Impact of the COVID-19 pandemic
The COVID-19 pandemic had a negative impact on the ophthalmic sutures industry as medical resources were redirected towards COVID-19 treatment. The industry was also impacted due to the postponement of all elective surgeries in outpatient and inpatient units. The vaccination drives also reported a rise in ocular complications post vaccine administration, which further delayed many ophthalmic surgeries globally, impeding product adoption. However, as the COVID-19 case load declines rapidly, medical facilities are being gradually redirected to elective procedures, enabling the market to chart a path to recovery.
The ophthalmic sutures market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Type
- Natural
- Synthetic
By Material
- Nylon
- Polyproplene
- Silk
- PGA
- Others
By Coating
- Coated
- Uncoated
By Material Structure
- Monofilament
- Multifilament/Braided
By Absorption
- Absorbable
- Non-absorbable
By Application
- Cataract Surgery
- Corneal Transplantation Surgery
- Glucoma Surgery
- Vitrectomy
- Oculoplastic surgery
- Others
By End-use
- Hospitals
- Ambulatory Surgical Centers
- Others
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE